Eisai Co. Ltd.

10/18/2021 | Press release | Distributed by Public on 10/17/2021 17:36

Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. Receive Positive EU CHMP Opinions for LENVIMA® (lenvatinib) Plus KEYTRUDA® (pembrolizumab) in Two Different Types of[...]

News release searchSearch